Company / Shareholders' Equity
CME Group Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$28.7B
FY2025
5-year range
$26.5B / $28.7B
FY2021-FY2025
Trend
+8.5%
vs FY2024
Sector context
#29 of 395
Financials
What the data says
Among 395 Financials companies, CME Group is in the top 7% for shareholders' equity. Shareholders' Equity returned to growth in FY2025 after 3 years of decline, reaching $28.7B.
Based on SEC 10-K filings.
$28.7B in FY2025 with a 5-year CAGR of +1.9%. Top quartile in the Financials sector.
Improved from $26.7B to $28.7B over the past 2 years.
Financials sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +1.9%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in FinancialsTop 7% of 395This company $28.7B Sector average $11.5B
▼
+150.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +1.9%, indicating consistent growth.
- In FY2025, shareholders' equity increased 8.5% year-over-year.
- Ranks #29 out of 395 companies in the Financials sector.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.7B | +8.5% |
| FY2024 | $26.5B | -0.9% |
| FY2023 | $26.7B | -0.5% |
| FY2022 | $26.9B | -1.9% |
| FY2021 | $27.4B | +4.9% |
| FY2020 | $26.1B | +0.8% |
| FY2019 | $25.9B | -0.2% |
| FY2018 | $26.0B | +15.9% |
| FY2017 | $22.4B | +10.2% |
| FY2016 | $20.3B | -1.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026